ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Passive Biotech

      Invesco Nasdaq Biotechnology ETF

      The Invesco Nasdaq Biotechnology ETF (the ¡°Fund¡±) seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology? Index?(the ¡°Underlying Index¡±).

      $23.80

      Compare similar ETFs

      Fund Size
      Dividend
      Fees
      Current
      Nasdaq Biotechnology ETF IBBQ
      Fund Size
      $45.4M
      Dividend
      1.0%
      Fees
      -
      Total Stock Market Index Fund VTSAX
      Fund Size
      $1.7T
      Dividend
      -
      Fees
      -
      Total Stock Market Index Fund VTI
      Fund Size
      $1.7T
      Dividend
      1.2%
      Fees
      0.03%
      500 Index Fund VFIAX
      Fund Size
      $1.49T
      Dividend
      -
      Fees
      -
      500 Index Fund VOO
      Fund Size
      $1.49T
      Dividend
      1.2%
      Fees
      0.03%
      View 1315 similar ETFs →

      Average metrics of all companies in portfolio

      Compare to
      Market
      Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $60.7B
      Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.9 %
      Beta Indicates the relationship between the price performance of a share and the market. 0.5588
      P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 27.71
      Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -41.9
      Profitable Companies 60
      PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 123.45
      Price to Sales Ratio Market cap divided by the revenue in the most recent year. 9.71
      Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 28.71
      Compare to
      Market
      Enterprise Value to EBIT Enterprise Value divided by EBIT -5.69
      Enterprise Value to Revenue Enterprise value divided by revenue 190.01
      Total Debt to Enterprise Value Total debt divided by enterprise value 0.11
      Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. NaN
      Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -5164.40%
      Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
      Return on Equity Equity divided by market cap. 16.07%
      Return on Assets Indicates a company's profitability in relation to its total assets. 4.82%
      Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -26.30%

      Industries

      Healthcare 82.3%
      Other 11.3%
      Materials 0.8%
      Finance 0.4%
      N/A 5.3%

      Market cap

      Micro Cap 1%
      Small Cap 10%
      Mid Cap 22%
      Large Cap 62%
      Mega Cap 5%

      266 Investments

      P/E-Ratio
      Total Investment
      Weight
      Invesco Private Prime Fund logo

      Invesco Private Prime Fund

      P/E-Ratio
      n/a
      Total Investment
      $6.98M
      Weight
      19.6%
      Gilead Sciences, Inc. logo

      GILD - Manufacturing

      Gilead Sciences, Inc.

      P/E-Ratio
      22.3
      Total Investment
      $3.09M
      Weight
      8.7%
      Amgen Inc. logo

      AMGN - Manufacturing

      Amgen Inc.

      P/E-Ratio
      23.4
      Total Investment
      $3M
      Weight
      8.4%
      Vertex Pharmaceuticals Inc. logo

      VRTX - Manufacturing

      Vertex Pharmaceuticals Inc.

      P/E-Ratio
      27.6
      Total Investment
      $2.96M
      Weight
      8.3%
      Invesco Private Government Fund logo

      Invesco Private Government Fund

      P/E-Ratio
      n/a
      Total Investment
      $2.74M
      Weight
      7.7%
      Regeneron Pharmaceuticals, Inc. logo

      REGN - Manufacturing

      Regeneron Pharmaceuticals, Inc.

      P/E-Ratio
      13.7
      Total Investment
      $2.11M
      Weight
      5.9%
      AstraZeneca PLC logo

      AZN - Health Technology

      AstraZeneca PLC

      P/E-Ratio
      29.2
      Total Investment
      $1.7M
      Weight
      4.8%
      Alnylam Pharmaceuticals, Inc. logo

      ALNY - Manufacturing

      Alnylam Pharmaceuticals, Inc.

      P/E-Ratio
      -181.5
      Total Investment
      $1.58M
      Weight
      4.4%
      Biogen Inc. logo

      BIIB - Manufacturing

      Biogen Inc.

      P/E-Ratio
      12.6
      Total Investment
      $760k
      Weight
      2.1%
      argenx SE logo

      ARGX - Manufacturing

      argenx SE

      P/E-Ratio
      46.3
      Total Investment
      $735k
      Weight
      2.1%
      United Therapeutics Corp. logo

      UTHR - Manufacturing

      United Therapeutics Corp.

      P/E-Ratio
      11.1
      Total Investment
      $573k
      Weight
      1.6%
      Royalty Pharma PLC logo

      RPRX - Manufacturing

      Royalty Pharma PLC

      P/E-Ratio
      14.9
      Total Investment
      $569k
      Weight
      1.6%
      Sanofi logo

      SNY - Health Technology

      Sanofi

      P/E-Ratio
      11.3
      Total Investment
      $567k
      Weight
      1.6%
      Summit Therapeutics Inc. logo

      SMMT

      Summit Therapeutics Inc.

      P/E-Ratio
      -23.6
      Total Investment
      $537k
      Weight
      1.5%
      Illumina, Inc. logo

      ILMN - Manufacturing

      Illumina, Inc.

      P/E-Ratio
      12.6
      Total Investment
      $521k
      Weight
      1.5%
      Insmed Inc. logo

      INSM - Manufacturing

      Insmed Inc.

      P/E-Ratio
      -24.9
      Total Investment
      $505k
      Weight
      1.4%
      Incyte Corp. logo

      INCY - Professional, Scientific, and Technical Services

      Incyte Corp.

      P/E-Ratio
      18.8
      Total Investment
      $504k
      Weight
      1.4%
      Neurocrine Biosciences, Inc. logo

      NBIX - Manufacturing

      Neurocrine Biosciences, Inc.

      P/E-Ratio
      39.7
      Total Investment
      $492k
      Weight
      1.4%
      Exelixis, Inc. logo

      EXEL - Professional, Scientific, and Technical Services

      Exelixis, Inc.

      P/E-Ratio
      16.9
      Total Investment
      $484k
      Weight
      1.4%
      BioMarin Pharmaceutical Inc. logo

      BMRN - Manufacturing

      BioMarin Pharmaceutical Inc.

      P/E-Ratio
      17.0
      Total Investment
      $443k
      Weight
      1.2%
      Viatris Inc. logo

      VTRS - Finance and Insurance

      Viatris Inc.

      P/E-Ratio
      -3.6
      Total Investment
      $421k
      Weight
      1.2%
      BeiGene Ltd. logo

      BGNE - Manufacturing

      BeiGene Ltd.

      P/E-Ratio
      -14.4
      Total Investment
      $410k
      Weight
      1.2%
      Moderna, Inc. logo

      MRNA - Manufacturing

      Moderna, Inc.

      P/E-Ratio
      -3.2
      Total Investment
      $409k
      Weight
      1.1%
      Ascendis Pharma A/S logo

      ASND - Manufacturing

      Ascendis Pharma A/S

      P/E-Ratio
      -37.1
      Total Investment
      $394k
      Weight
      1.1%
      BioNTech SE logo

      BNTX - Manufacturing

      BioNTech SE

      P/E-Ratio
      -59.1
      Total Investment
      $382k
      Weight
      1.1%
      HoMEÔçÒÒŮѸÀ×